Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages

09/10/2025 32 min Episodio 526
Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages

Listen "Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages"

Episode Synopsis

touchEXPERT FOCUS for touchONCOLOGY

Listen to insights from Prof. Jean-Pascal Machiels on optimizing the use of immunotherapy in patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) and the potential future role of immunotherapy in resectable locally advanced HNSCC.

The expert:

Prof. Jean-Pascal Machiels, Cliniques universitaires Saint-Luc, Brussels, Belgium

This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.

For further information visit our website: www.touchONCOLOGY.com

More episodes of the podcast touchPODCAST